# Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)

Study · id `cardio:ct-nct01279590` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01279590](<https://clinicaltrials.gov/study/NCT01279590>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01279590

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 282 participants.

## Technical summary

Registry record NCT01279590. Randomized; quadruple masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2011-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 282 participants (enrolled count; ClinicalTrials.gov record NCT01279590, source copy `cardio:ctgov-nct01279590-2011-12-22`, retrieved 2026-10-31)
- Start date: 2011-03 (registry gives no type) (ClinicalTrials.gov record NCT01279590, source copy `cardio:ctgov-nct01279590-2011-12-22`, retrieved 2026-10-31)
- Primary completion: 2011-11 (actual) (ClinicalTrials.gov record NCT01279590, source copy `cardio:ctgov-nct01279590-2011-12-22`, retrieved 2026-10-31)
- Completion: 2011-11 (actual) (ClinicalTrials.gov record NCT01279590, source copy `cardio:ctgov-nct01279590-2011-12-22`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT01279590, source copy `cardio:ctgov-nct01279590-2011-12-22`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01279590-2011-12-22`, retrieved 2026-10-31)

## The registry's words

- Brief title: Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
- Condition: Myalgia
- Condition: Hypercholesterolemia
- Condition: Hyperlipidemia
- Intervention (Drug): PPD10558
- Intervention (Drug): Atorvastatin
- Intervention (Drug): Placebo
- Lead sponsor: Furiex Pharmaceuticals, Inc
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)

## Provenance

Content hash: 7ad980993cd2208e6049798891ca8d4a9a66a74be3e0fccfd0658b867a3e24e6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
